Detalles de la búsqueda
1.
A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System.
Ann Surg Oncol
; 30(4): 2095-2103, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542249
2.
Improvement in patient-reported pain among patients with metastatic cancer and its association with opioid prescribing.
Support Care Cancer
; 31(7): 427, 2023 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37369812
3.
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer.
Br J Cancer
; 126(6): 881-888, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931041
4.
New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.
BMC Cancer
; 22(1): 281, 2022 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296284
5.
Documenting patients' and providers' preferences when proposing a randomized controlled trial: a qualitative exploration.
BMC Med Res Methodol
; 22(1): 64, 2022 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249528
6.
Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer
Can J Surg
; 63(2): E100-E109, 2020 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32109016
7.
Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer.
J Natl Compr Canc Netw
; 17(8): 957-967, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390594
8.
Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer.
J Natl Compr Canc Netw
; 17(1): 47-56, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30659129
9.
The ONE-MIND Study: Rationale and protocol for assessing the effects of ONlinE MINDfulness-based cancer recovery for the prevention of fatigue and other common side effects during chemotherapy.
Eur J Cancer Care (Engl)
; 28(4): e13074, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31056784
10.
ASO Visual Abstract: A New Method of Identifying Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System.
Ann Surg Oncol
; 30(4): 2106-2107, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646922
11.
Premature mortality due to breast cancer among Canadian women: an analysis of a 30-year period from 1980 through 2010.
Eur J Public Health
; 28(2): 348-352, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29112730
12.
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Breast Cancer Res Treat
; 157(1): 109-16, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116183
13.
Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?
J Natl Compr Canc Netw
; 13(6): 762-71, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26085392
14.
Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive Breast Cancer.
JAMA Netw Open
; 7(3): e242082, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477918
15.
The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 15(7)2023 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046584
16.
Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status.
Curr Oncol
; 29(1): 383-391, 2022 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35049708
17.
A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab.
Curr Oncol
; 29(6): 4224-4234, 2022 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735446
18.
Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study.
Int J Radiat Oncol Biol Phys
; 114(3): 399-408, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870712
19.
Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches.
JCO Clin Cancer Inform
; 6: e2100055, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35148170
20.
First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta.
Curr Oncol
; 28(3): 2270-2280, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34207443